biotin has been researched along with yttrium radioisotopes in 30 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (yttrium radioisotopes) | Trials (yttrium radioisotopes) | Recent Studies (post-2010) (yttrium radioisotopes) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 3,407 | 339 | 1,533 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 19 (63.33) | 29.6817 |
| 2010's | 5 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hnatowich, DJ; Virzi, F; Wu, C | 1 |
| Chinol, M; Fazio, F; Meares, C; Paganelli, G; Sudati, F | 1 |
| Chinol, M; Cremonesi, M; De Braud, F; Grana, C; Jereczek-Fossa, B; Orecchia, R; Paganelli, G; Tradati, N | 1 |
| Goodwin, DA; Meares, CF; Osen, M | 1 |
| Casadio, C; Chinol, M; Cremonesi, M; De Braud, F; De Cicco, C; Grana, C; Paganelli, G; Robertson, C; Siccardi, AG; Veronesi, U; Zoboli, S; Zurrida, S | 1 |
| Adams, GP; Axworthy, D; Breitz, H; Bryan, K; Colcher, D; Fisher, DR; Gaffigan, S; Gentner, L; Goris, ML; Horak, ID; Knox, SJ; Tempero, M; Weiden, PL; Weiner, LM | 1 |
| Domingo, RJ; Reilly, RM | 1 |
| Appelbaum, JW; Axworthy, D; Breitz, HB; Bryan, JK; Fisher, D; Gaffigan, S; Press, O; Reno, J; Stone, D; Weiden, PL | 1 |
| Breitz, HB; Fisher, DR; Goris, ML; Knox, S; Murtha, AD; Ratliff, B; Weiden, PL | 1 |
| Bartolomei, M; Broggi, G; Caliceti, P; Chinol, M; Cremonesi, M; Ferrari, M; Gatti, M; Grana, C; Maira, G; Paganelli, G; Prisco, G; Sturiale, C | 1 |
| Bartolomei, M; Caliceti, P; Chinol, M; De Cicco, C; Fiorenza, M; Gatti, M; Grana, C; Mazzetta, C; Paganelli, G; Robertson, C | 1 |
| Axworthy, D; Hedin, N; Mallet, R; Matthews, DC; Meyer, D; Pagel, JM; Press, OW; Subbiah, K; Theodore, LJ; Wilbur, DS | 1 |
| Weiden, PL | 1 |
| Carrasquillo, JA; Eckelman, WC; Garmestani, K; Googins, S; Paik, CH; Park, LS; Plascjak, PS; Szajek, LP; Wong, KJ | 1 |
| Bartolomei, M; Bodei, L; Chinol, M; Colombo, N; Grana, C; Handkiewicz, D; Malavasi, F; Mangioni, C; Paganelli, G; Rocca, P | 1 |
| Bartolomei, M; Bodei, L; Grana, C; Handkiewicz-Junak, D; Maira, G; Mazzetta, C; Paganelli, G; Rocca, P; Sturiale, C; Villa, G | 1 |
| Axworthy, DB; Besh, S; Breitz, H; Chen, KH; Forero-Torres, A; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Percent, I; Shen, S; Sims, RB | 1 |
| Cavallin-Ståhl, E; Garkavij, M; Kurkus, J; Lindén, O; Ljungberg, M; Nilsson, R; Ohlsson, T; Sandberg, B; Strand, SE; Tennvall, J | 1 |
| Mårtensson, L; Nilsson, R; Ohlsson, T; Senter, P; Sjögren, HO; Strand, SE; Tennvall, J; Wang, Z | 1 |
| Cardillo, TM; Chang, CH; Goldenberg, DM; Horak, ID; Karacay, H; McBride, WJ; Rossi, EA; Sharkey, RM | 1 |
| Axworthy, DB; Buchsbaum, DJ; Carpenter, M; Chaudhuri, TR; Khazaeli, MB; LoBuglio, AF; Schultz, J; Zinn, KR | 1 |
| Buchsbaum, DJ; Meredith, RF | 1 |
| Carminati, P; Cremonesi, M; De Cicco, C; Ferrari, M; Fiorenza, M; Galimberti, V; Luini, A; Orecchia, R; Paganelli, G; Veronesi, P; Veronesi, U; Zanna, C | 1 |
| Carminati, P; Chinol, M; Cremonesi, M; De Cicco, C; De Santis, R; Ferrari, M; Fiorenza, M; Galimberti, V; Luini, A; Paganelli, G; Papi, S; Ravasi, L; Sivolapenko, G; Travaini, LL; Veronesi, U; Zanna, C | 1 |
| Appelbaum, FR; Fisher, DR; Gopal, AK; Hamlin, DK; Kenoyer, A; Lin, Y; Matthews, DC; Pagel, JM; Press, OW; Saganic, L; Wilbur, DS | 1 |
| Carbone, G; Cremonesi, M; De Cicco, C; De Santis, R; Di Dia, A; Ferrari, A; Ferrari, ME; Galimberti, V; Leonardi, MC; Luini, A; Orecchia, R; Pacifici, M; Paganelli, G; Pagani, G; Veronesi, U; Zurrida, S | 1 |
| Chinol, M; Garaboldi, L; González, IH; Montaña, RL; Ramirez, AA | 1 |
| Botta, F; Calabrese, M; Cremonesi, M; De Cicco, C; Di Dia, A; Ferrari, ME; Orecchia, R; Paganelli, G; Pedicini, P; Pedroli, G; Sarnelli, A | 1 |
| Albertoni, C; Carollo, V; D'Alessio, V; De Santis, R; Leoni, B; Rosi, A; Spagnoli, LG; van Echteld, C | 1 |
| Hanaoka, H; Katsumata, N; Tsushima, Y; Yamaguchi, A; Yudistiro, R | 1 |
1 review(s) available for biotin and yttrium radioisotopes
| Article | Year |
|---|---|
Pretargeted radioimmunotherapy.
Topics: Animals; Antibodies, Bispecific; Antibody Specificity; Biotin; Clinical Trials, Phase I as Topic; Humans; Mice; Mice, Nude; Models, Animal; Neoplasms; Radioimmunotherapy; Streptavidin; Transplantation, Heterologous; Yttrium Radioisotopes | 2006 |
10 trial(s) available for biotin and yttrium radioisotopes
| Article | Year |
|---|---|
Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Biotin; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Tenascin; Tissue Distribution; Whole-Body Counting; Yttrium Radioisotopes | 1999 |
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.
Topics: Adult; Aged; Anemia; Antibodies, Monoclonal; Biotin; Colonic Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radiopharmaceuticals; Thrombocytopenia; Yttrium Radioisotopes | 2000 |
Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results.
Topics: Adult; Antigens, CD20; Biotin; Female; Humans; Immunoglobulin G; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Fusion Proteins; Tissue Distribution; Yttrium Radioisotopes | 2000 |
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results.
Topics: Adult; Aged; Antibodies, Monoclonal; Avidin; Biotin; Brain Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Radiotherapy Dosage; Tenascin; Tissue Distribution; Yttrium Radioisotopes | 2001 |
Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Avidin; Biotin; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Immunoconjugates; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2002 |
Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide.
Topics: Antineoplastic Agents, Alkylating; Biotin; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Delivery Systems; Female; Glioblastoma; Humans; Italy; Male; Middle Aged; Radioimmunotherapy; Radiopharmaceuticals; Survival Analysis; Temozolomide; Treatment Outcome; Yttrium Radioisotopes | 2004 |
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Biotin; Clinical Trials as Topic; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Gamma Cameras; Gastrointestinal Neoplasms; Glycoproteins; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Recombinant Fusion Proteins; Rhenium; Streptavidin; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2005 |
A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
Topics: Adsorption; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Biotin; Biotinylation; Cell Line, Tumor; Clinical Trials as Topic; Hemadsorption; Humans; Immunoconjugates; Indium Radioisotopes; Kidney; Liver; Lymphoma, B-Cell; Radioimmunodetection; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rituximab; Time Factors; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2005 |
Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer.
Topics: Adolescent; Adult; Aged; Avidin; Biotin; Brachytherapy; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Indium Radioisotopes; Injections, Intralesional; Injections, Intravenous; Intraoperative Period; Mastectomy, Segmental; Middle Aged; Organometallic Compounds; Pilot Projects; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sentinel Lymph Node Biopsy; Tissue Distribution; Yttrium Radioisotopes | 2007 |
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.
Topics: Adult; Aged; Avidin; Biotin; Breast Neoplasms; Drug Delivery Systems; Female; Humans; Intraoperative Care; Middle Aged; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy, Adjuvant; Treatment Outcome; Yttrium Radioisotopes | 2010 |
19 other study(ies) available for biotin and yttrium radioisotopes
| Article | Year |
|---|---|
Investigations of N-linked macrocycles for 111In and 90Y labeling of proteins.
Topics: Amines; Animals; Avidin; Biotin; Chelating Agents; Drug Stability; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Mice; Pentetic Acid; Proteins; Tissue Distribution; Yttrium Radioisotopes | 1992 |
Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting.
Topics: Adenocarcinoma; Animals; Avidin; Beta Particles; Biotin; Bone and Bones; Colonic Neoplasms; Humans; Liver; Male; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Time Factors; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 1997 |
Combined treatment of advanced oropharyngeal cancer with external radiotherapy and three-step radioimmunotherapy.
Topics: Aged; Biotin; Carcinoma, Squamous Cell; Humans; Male; Oropharyngeal Neoplasms; Radioimmunotherapy; Radiotherapy, High-Energy; Tonsillar Neoplasms; Yttrium Radioisotopes | 1998 |
Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Topics: Animals; Biotin; Chelating Agents; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, SCID; Radioimmunodetection; Radioimmunotherapy; Streptavidin; Tissue Distribution; Yttrium Radioisotopes | 1998 |
Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Biomarkers, Tumor; Biotin; Colonic Neoplasms; Glycoproteins; Humans; Indicators and Reagents; Mice; Mice, Nude; Neoplasm Transplantation; Organometallic Compounds; Radioimmunotherapy; Streptavidin; Transplantation, Heterologous; Yttrium Radioisotopes | 2000 |
Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Biotin; Dose-Response Relationship, Radiation; Humans; Indium Radioisotopes; Kinetics; Organometallic Compounds; Phantoms, Imaging; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Streptavidin; Tissue Distribution; Yttrium Radioisotopes | 1999 |
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; Biotin; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Leukocyte Common Antigens; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organometallic Compounds; Radioimmunotherapy; Remission Induction; Streptavidin; Tumor Cells, Cultured; Yttrium Radioisotopes | 2003 |
Pretargeted radioimmunotherapy (PRIT) using an antibody-streptavidin fusion protein in non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Biotin; Female; Humans; Immunoconjugates; Indium Radioisotopes; Lymphoma, Non-Hodgkin; Middle Aged; Radioimmunotherapy; Recombinant Fusion Proteins; Rhenium; Streptavidin; Tissue Distribution; Yttrium Radioisotopes | 2002 |
Semi-automated 86Y purification using a three-column system.
Topics: Biotin; Chromatography; Isotope Labeling; Organometallic Compounds; Protein Binding; Radiopharmaceuticals; Robotics; Strontium Isotopes; Yttrium Radioisotopes | 2004 |
Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with (90)Y-biotin?
Topics: Adult; Aged; Antibodies, Monoclonal; Biotin; Female; Humans; Immunotoxins; Middle Aged; Ovarian Neoplasms; Radioimmunotherapy; Retrospective Studies; Salvage Therapy; Yttrium Radioisotopes | 2004 |
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
Topics: Animals; Antibodies, Monoclonal; Biotin; Body Weight; Brain; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 1-Ring; Leukocytes; Lutetium; Maximum Tolerated Dose; Platelet Count; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Time Factors; Yttrium Radioisotopes | 2005 |
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
Topics: Animals; Antibodies, Monoclonal; Avidin; Biotin; Calibration; Cell Line, Tumor; Contrast Media; DNA; DNA, Complementary; Drug Delivery Systems; Female; Gamma Rays; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Neoplasms; Oligonucleotides; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Recombinant Proteins; Streptavidin; Time Factors; Ultrasonics; Yttrium Radioisotopes | 2005 |
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Biotin; Cell Line, Tumor; Colonic Neoplasms; Glycoproteins; Humans; Indium Radioisotopes; Injections, Intraperitoneal; Iodine Radioisotopes; Lutetium; Mice; Mice, Nude; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Streptavidin; Survival Analysis; Time Factors; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2005 |
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation.
Topics: Adult; Avidin; Biotin; Brachytherapy; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Injections, Intralesional; Injections, Intravenous; Intraoperative Period; Mastectomy, Segmental; Middle Aged; Radiometry; Radionuclide Imaging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Yttrium Radioisotopes | 2007 |
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.
Topics: Animals; Antibodies, Monoclonal; Biotin; Female; Humans; Immunotoxins; Indium Radioisotopes; Leukemia, Myeloid; Leukocyte Common Antigens; Lymphoid Tissue; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioimmunotherapy; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2009 |
Yttrium-90 -- current status, expected availability and applications of a high beta energy emitter.
Topics: Antibodies, Monoclonal, Humanized; Beta Particles; Biotin; Breast Neoplasms; Cation Exchange Resins; Equipment Design; Female; Humans; Organometallic Compounds; Radionuclide Generators; Radiopharmaceuticals; Yttrium Radioisotopes | 2012 |
3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy.
Topics: Avidin; Biotin; Breast Neoplasms; Female; Humans; Multimodal Imaging; Organometallic Compounds; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2012 |
Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.
Topics: Animals; Avidin; Biotin; Dogs; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Organometallic Compounds; Rabbits; Radioimmunotherapy; Swine; Tongue Neoplasms; Yttrium Radioisotopes | 2015 |
Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase.
Topics: Animals; Avidin; Bevacizumab; Biotin; Cell Line, Tumor; Female; Humans; Immunoconjugates; Metabolic Clearance Rate; Mice, Inbred BALB C; Mice, Nude; Radioimmunotherapy; Tissue Distribution; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2018 |